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“Gentlemen, we will skip the next chapter, since there are no recognized diseases of 
the small intestine, except tuberculosis.” 
Professor Evan M. Evans holding a lecture for the medical student Burril B. Crohn 
 
 
“I can’t believe schools are still teaching kids about the null hypothesis. I remember 
reading a big study that conclusively disproved it years ago.” 
XKCD 
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ABSTRACT 
Crohn’s disease (CD) is a chronic inflammatory bowel disease which often presents 
early in life and sometimes can be debilitating. The patients need frequent diagnostic 
work-up to assess disease activity, location, extent and if complications have occurred. 
This warrants diagnostic tools which are of little nuisance to the patient, available, 
affordable and objective. Diagnostic ultrasound imaging could potentially fulfil these 
criteria. A specific problem in patients with CD is the differentiation of inflammation 
and fibrosis in the thickened bowel wall when an obstruction develops. Improved 
differentiation could lead to better tailoring of treatment. 
The main aim of this thesis was to examine if there were ultrasound criteria which 
could separate fibrosis and inflammation. 
In the first study 14 bowel specimens from patients operated for CD was examined 
with ultrasound in vitro and compared directly to histology. We found that some 
histological findings typical for CD which cannot be investigated in mucosal biopsies 
can be identified with ultrasound. A thickened muscular mucosa, echo changes in the 
submucosa and proper muscles are features of fibrotic disease while lymphocyte 
aggregates along the outer border of muscularis propria is a feature of chronic 
inflammation. 
Since the main measurement used for detecting bowel disease is bowel wall thickness 
and proper reference values were wanting, study two was performed. The bowel wall 
thickness was measured in several locations in the gastrointestinal tract in 122 healthy 
volunteers. The results indicated that the normal bowel wall should not exceed 2 
millimetres in most of the GI tract except for the stomach, duodenum and rectum. 
Furthermore, the reference values can be used for ultrasound probes with a frequency 
>8 megahertz regardless of fasting state, age, weight sex and height. 
In paper three two patient groups allocated for medical treatment (n=19) or surgical 
treatment (n=20) through a regular clinical work up were compared to identify features 
separating the two groups.  Contrast enhanced ultrasound was used in combination 
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with a perfusion model to estimate blood flow in the bowel wall. We found that the 
surgical group had decreased blood volume and flow when compared to the medical 
group and markedly thicker bowel wall including the muscularis propria and mucosa. 
From our results we conclude that a thickened muscular mucosa and echo changes in 
the submucosa as well as a reduced blood volume and flow could be indications of 
fibrostenotic disease and thus might support a decision for surgical treatment. Work 
remains on verifying the perfusion results with histology and to see if these findings 
can be reproduced in a larger group of patients. The perfusion model also needs further 
validation before implementation in regular clinical work. 
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 INTRODUCTION 1.
  Crohn’s disease 1.1
1.1.1 Background  
Crohn’s disease (CD) is a chronic inflammatory disease of the gastrointestinal (GI) 
tract named after one of the first to recognize it as a clinical entity in 1932 (1).  Case 
reports have documented the disease back to 1769 (2).  
The incidence of CD is higher in western, industrialized countries with an increasing 
incidence from south to the north in the northern hemisphere and including New 
Zealand and Australia in the southern hemisphere (3). In Norway, recent studies from 
the south-eastern part of the country show that the incidence of CD for those <16 years 
was about 6.9/ 100 000 in the period 2005-2007 while it was around 2.8 in the period 
from 1993-2004 (4;5). The overall incidence for a larger region in south eastern 
Norway was found to be 5,8/ 100 000 for the period 1990-93 (6). Prevalence in 
Norway is not known, but since mortality is not substantially increased in patients with 
CD and median age at diagnosis is about 30 years, in time one  should expect 
prevalence of around 300/100 000 with a stable incidence. 
CD affects the full depth of the GI wall and has a remitting course with inflammation 
and repair. It is also associated with complications such as fistulas, abscesses, 
intestinal perforation and obstruction of the intestinal lumen through the formation of 
strictures and stenosis. 
The afflicted are usually young when first diagnosed and need frequent diagnostic care 
to evaluate disease activity and treatment effect. There is often a large discrepancy 
between symptoms and disease activity. This warrants a diagnostic tool that is 
objective, causes little patient distress and cumulative risk, is cost efficient and can 
show both the affected intestine and the peri-intestinal complications. Transabdominal 
ultrasound (US) could potentially fill many of these roles. 
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This thesis is focused on describing ultrasonographic findings in the intestinal wall in 
patients with CD using high frequency US probes and contrast-enhanced ultrasound 
and how these findings relate to findings in the healthy subjects, clinical outcome, 
histology and biochemical tests. Patients with only perianal CD are not a subject in 
this thesis as the focus is on transabdominal ultrasound. 
1.1.2 Symptoms and findings 
Symptoms and findings in CD depend on the location of disease in the GI tract or if 
complications have occurred. Typical symptoms at the time of diagnosis are long-
lasting diarrhoea (85%) with or without traces of blood, abdominal pain (70%), and 
fatigue, anorexia and weight loss (60%).  
Some patients present with complicated disease already at the time of diagnosis with 
GI obstruction symptoms due to stenosis, fistulas or abscesses. The interval between 
disease debut and time of diagnosis could be caused by patient’s delay, doctor’s delay 
or simply due to longstanding, indolent disease (7;8). 
Some patients present with perianal disease (1-30%) (9), suspected appendicitis (10)  
and others also have extra-intestinal manifestations such as arthritis, sacro-ileitis, 
uveitis, erythema nodosum, pyoderma gangrenosum or kidney stones (8). 
There is no biochemical test in blood or faeces that is specific for CD. Prolonged blood 
loss through bloody diarrhoea causes iron deficiency and lowered haemoglobin, but 
anaemia can also be a consequence of chronic inflammation, or CD associated vitamin 
B12 or folat deficiency (11). With pronounced inflammation there is an increase in 
leucocyte and platelet count and C-reactive protein (CRP), which are general markers 
of inflammation. Serum-albumin has a negative correlation with other activity 
markers, but this is rather unspecific, as both malnutrition and malabsorption, 
complications that could occur in these patients, also cause lowered albumin levels 
(12). Stool samples can be analysed for lactoferrin and calprotectin which both are 
markers of the migration of polymorphonuclear leucocytes to the intestinal mucosa. 
These are both more sensitive to intestinal inflammation than CRP, but not specific to 
CD (13). 
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1.1.3 Macroscopic and histological findings 
In CD there is typically a patchy spread of disease in the bowel. In the affected areas, a 
thick, stiffened bowel wall with hypertrophy of the serosal fat, or fatty wrapping, can 
be found. Stenosis, fistulas and abscesses are other typical findings (14-16). When the 
specimen is cut open typical findings are deep, serpiginous and longitudinal ulcers, 
cobblestone appearance of the ileum, skip lesions and strictures (17).  
In mucosal biopsies granulomas are pathognomonic of CD, but they are more frequent 
in children (about 50%) than in adults (about 20%).  This is probably a reflection of 
that granulomas can be found more frequently in the early stages of the disease (18). In 
the same histological sections both normal crypts and crypts invaded by neutrophils, 
can be seen.  
CD does, however, affect the wall transmurally. In full wall biopsies from operation 
specimens several other structures typical of CD can be found. Such features as a 
thickening of the muscularis mucosa (19), perivascular inflammation and 
inflammation of plexus myentericus are also common. A thickened muscularis mucosa 
is often associated with submucosal fibrosis (20). Lymphocyte aggregates can be 
found throughout the GI wall, also along the outer border of muscularis propria. These 
aggregates are a typical feature of CD and resemble a string of rosary beads when seen 
in cross section, hence the term Crohn’s rosary (17). 
1.1.4 Imaging in Crohn’s disease 
Endoscopy, particularly ileocolonoscopy, is currently the main tool for detecting CD. 
It allows inspection of the intestinal mucosa from the terminal ileum to the rectum and 
biopsies from all the inspected areas can be obtained. CD lesions can typically be 
found in any segment of the GI tract. Typical findings are as previously described. For 
study purposes there are validated indexes such as the simple endoscopic index of 
Crohn’s disease (SES-CD) which can be useful for quantifying endoscopic disease 
activity (21). 
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Conventional small bowel enteroclysis and small bowel follow through was the main 
method for the diagnosis of CD in the small bowel for a long time and experienced 
examiners could diagnose CD with high sensitivity and specificity (22). Unfortunately, 
only the superficial and intraluminal features of the gastrointestinal wall can be 
evaluated and the extra-intestinal features of CD cannot be seen with these modalities. 
Computer tomography enterography has high sensitivity and specificity for detection 
of disease, relapse and complications. Due to the cumulative load of ionizing radiation 
with repeated examinations it is not considered suitable for the follow up of CD 
patients, however (23). 
Magnetic resonance imaging (MRI) enterography or enteroclysis has been shown to 
have a good accuracy for diagnosing CD, detecting the extent of disease, disease 
activity in the small bowel and for detecting extra-intestinal complications (23). To 
obtain high quality images fast imaging sequences in combination with drugs that 
reduce motility are needed. The intestine should be properly distended which is 
achieved either through installation of contrast via a naso-jejunal tube or per-oral 
ingestion. Intravenous contrast with gadolinium is used to evaluate bowel wall 
vascularity and perfusion. MRI has been suggested as the imaging modality for 
assessing bowel damage in CD (Lemann score) due to its good accuracy and non-
ionizing nature (24). To obtain proper images of the whole GI tract, however, several 
different imaging sequences must be used. The availability cost of MRI and strain on 
the patient are arguments against such an implementation. 
Diagnostic ultrasound 1.2
1.2.1 General 
Ultrasound is sound that cannot be detected by the human ear, which means it must 
have a frequency above 20 000 Hertz (Hz). Typically diagnostic US is in the 
frequency range of 1000 000 Hz, or 1 Mega-hertz (MHz), to 40 MHz. Sound waves 
can be mathematically described as  
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ߣ ൌ ௖௙   (1) 
Where Ȝ=the wavelength, f=frequency and c=speed of sound through a medium. This 
means that if the speed does not change, wavelength is directly proportional to the 
frequency. For most US scanners the speed of sound is defined as 1540 m/s which is 
the average sound speed through different human tissues. 
In an US probe the ultrasound is emitted and received by one or more piezoelectric 
(PE) crystals. Axial resolution is dependent on the spatial pulse length (SPL) which is 
derived from the equation 
ܵܲܮ ൌ ߣ ൈ ݊   (2) 
Where n=the number of pulses per cycle. This means that a high frequency transducer 
(>7.5MHz) with a short pulse length will give better axial resolution than a low or 
median frequency transducer with a longer pulse length. The lateral resolution is 
dependent on the number of PE-crystals and focusing of the ultrasound beam. 
The ultrasound wave is attenuated in the tissue through absorption, reflection and 
diffraction. It is the reflected sound that can be registered by the US probe. To 
compensate for the loss of return-signal or echo due to attenuation most scanners have 
time-gain compensation which basically enhances the return echo according to the 
time from the last pulse. 
1.2.2 B-mode 
In real-time B-mode (Brightness mode) imaging the echo from a specific depth is 
registered by a PE crystal and represented as a point of intensity varying according to 
the amplitude of the echo. Echo points from all the depths registered along the scan 
line of one PE crystal together with the scan lines of the other PE crystals are 
combined into an image.  
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1.2.3 Doppler 
The different Doppler methods are based on the Doppler effect which causes a shift in 
frequency when a wave is reflected or emitted from an object in relative motion to the 
observer. It is mostly used for the detection and measurement of blood velocity. For 
reflected US it can be described by the equation 
ߜ݂ ൌ ʹ ൈ ሺ݂݁ ൈ ݒܾ ൈ ୡ୭ୱఏ௖ ሻ  (3) 
where įf = change in frequency, fe = emitted frequency, vb =speed of blood, ș =the 
angle between the ultrasound beam and the blood vessel and c =  speed of sound in the 
medium.  
With colour Doppler the speed and direction of blood moving within the analysed 
sector is represented with colours of different hues and intensity. Typically, blue 
colour represents movement away from the US probe while red colour represents 
movement towards the probe.  Higher colour intensity indicates higher blood velocity. 
Examination of the GI wall typically warrants high sensitivity for the slow moving 
blood in small arteries and the scale should be set lower than ± 5cm/s. 
With pulse wave Doppler the Doppler shift is measured within a defined region along 
the US beam. If the angle between the blood flow and the US beam is known, the 
actual velocity of the blood within the vessel can be measured. Spectral pulse wave 
Doppler allows measurement of the average velocity which together with the cross 
sectional vessel area enables calculation of the actual blood flow. Resistive index (RI) 
is another useful parameter which is based on the relationship between the peak 
systolic (PSV) and end diastolic velocities (EDV). It is calculated as follows: 
ܴܫ ൌ ௉ௌ௏ାா஽௏௉ௌ௏   (4) 
This parameter has no units and gives a value between 0 and 1. It describes the blood 
flow resistance within the vessel and is independent of the angle between the US beam 
and the vessel. The combination of the colour Doppler information on the B-mode 
image coupled with spectral pulse wave Doppler is called triplex scanning. In this 
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modality the information from the colour Doppler image can used as a guide to place 
the pulse wave Doppler sample region which is particularly useful in the intestinal 
wall where the vessels are small (25). 
1.2.4 Ultrasonography of the GI tract 
The GI wall has a layered appearance on US images and according to the quality of the 
scanning system five to nine layers can be seen. The layers correlate to the histological 
layers to a certain degree. However, due to interface echoes the size and borders of the 
US layers differ slightly from the histological layers (26-30)(See figure 1, Paper II). 
When none of the wall layers can be seen with high frequency US, there is loss of 
stratification. 
GI wall thickness measurements in healthy volunteers have indicated values between 
0.9- 2 mm in the small intestine and 1.4-4.6 mm in the large intestine (31-35). In 
clinical studies 3-4 mm is typically used as a cut off between normal and pathological 
bowel wall (36-40). 
In many European countries transabdominal US has been used for a long time in the 
diagnosis and follow-up of CD patients. US of the bowel can be performed by an 
experienced operator without technical assistance. Typically an US scanner with a 
curvilinear abdominal probe (1-5MHz) and a linear probe with a higher frequency 
range (7-15 MHz) are used (41). No preparation of the patient is required, the 
examination causes little discomfort or cumulative risk for the patients and the 
equipment has low buying and running costs when compared to CT and MRI. Another 
major advantage is that US of most of the GI tract from the stomach to the rectum can 
be performed during a relatively short time. 
An US finding in patients with CD is often a thickened bowel wall in the range of 3 to 
15 millimetres. US can also detect stenosis and extra-intestinal features like fatty 
wrapping, mesenterial lymph nodes, abscesses and fistulas (Figure 1)(42;43).  
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Figure 1: Stenosis in the terminal ileum with fatty wrapping and prestenotic 
dilatation. 
For primary diagnostics and detection of relapse of CD ultrasonography has a high 
sensitivity (86-95%) and specificity (93-97%) which is comparable to MRI and CT 
(44-46). Ultrasonography is, however, less sensitive in the detection of deeply located 
abscesses and fistulas than the other techniques (47-49). These problems are mainly an 
issue in obese patients or patients with deeply located lesions in the lesser pelvis (50). 
Few studies explore the relationship between US findings and the differentiation 
between inflammation and fibrosis in the GI wall. Maconi et al. found that a thickened 
GI wall with preserved stratificcation in patients with otherwise low disease activity 
suggested that a stenosis was fibrotic while loss of stratification suggested an 
inflammatory stenosis (51;52). If the affected bowel section is shorter than 2 cm, this 
might also suggest intramural fibrosis (53). 
Continuous Doppler examinations of central vessels supplying the intestine such as the 
superior and inferior mesenteric arteries have shown that increased perfusion seems to 
be related to disease activity (54;55) . The challenge of using flow in these vessels as 
an indicator of disease activity is, however, that there is a large intra-individual 
variation making it difficult to suggest a reliable cut-off (51;54).  Furthermore, other 
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factors may also influence the results such as disease location, previous surgery and GI 
wall thickness (56). 
Assessing flow locally in the affected GI wall may be more useful since there are 
fewer confounding factors. This has been explored using a semi-quantitative scoring 
system with colour Doppler (57;58) as well as quantification through pixel analysis of 
colour Doppler recordings (59). Such Doppler techniques require strict standardization 
making them difficult to implement in clinical routine and sensitivity is markedly 
reduced with increasing depth (53). Yet another approach has been to measure the 
resistive index of intramural arteries in the GI wall. Some studies have shown promise 
yielding useful cut-off values (57;60;61). In practice, such measurements are difficult 
and quite often intramural arteries are not detected. 
Finally, contrast-enhanced ultrasound (CEUS) techniques have been applied in 
patients with CD. Mostly, a semi-quantitative approach has been used, but two studies 
indicate that some parameters derived from the analysis of contrast intensity over time 
correlates with the degree of inflammation on histology (62;63). Recent studies also 
show that, CEUS can be used to separate inflammatory lesions from fibrotic lesions 
(62-64). 
 Contrast-enhanced ultrasound and perfusion 1.3
1.3.1 Microbubbles and contrast-enhanced ultrasound 
In this thesis, the term contrast enhanced ultrasound (CEUS) is applied to the 
combination of intravenous administration of microbubbles and the detection of these 
bubbles using ultrasound. 
Microbubbles are gas-filled bubbles which are small enough to pass the smallest 
capillaries in the body, the pulmonary capillaries which means that they have to be less 
than 7 micrometre (μm) in diameter (Figure 2). 
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Figure 2: Sonovue microbubbles consist of a phospholipid monolayer enveloping 
sulphurhexafluoride gas with a diameter between 1-10 μm. The microbubbles are 
drawn to scale in a capillary.
One of the key elements of a microbubble is its gas content. In principle, it can be any 
gas since it is the compressibility of a gas in comparison to the near-incompressibility 
of tissue which is exploited in imaging. In practice, however, it should be a 
biologically inert gas, and it should have a high molecular weight since this reduces 
diffusion speed. Another important component is the shell of the microbubble. It 
should be biologically inert as well and promote stability and a long bubble life, but it 
also affects the resonance features of the microbubble. Commonly, a phospholipid 
shell is used (65;66). 
Sonovue (Bracco, Milan, Italy) consist of a monolayer phospholipid shell encasing the 
hydrophobic gas sulphur hexafluoride (SF6). The suspension contains from 100-500 
million microbubbles/millilitre, 80% of the microbubbles have a diameter less than 8 
μm, the average bubble diameter is 2.5 μm and the size range is from 0.7-10 μm  (67). 
It is currently the only US contrast agent approved for non-cardiac use in Norway. 
The unique behaviour of microbubbles has led to a rapidly expanding field of bubble 
physics. There are two main aspects which are crucial in relation to perfusion 
quantification. First, some microbubbles such as Sonovue are true intravascular agents, 
which mean that they do not leak into the extravascular space between the endothelial 
cells and are not phagocytized. In this way, they behave like erythrocytes and 
anywhere there is blood flow microbubbles can be detected. Secondly, the 
microbubbles resonate in an US field giving a non-linear response that can be 
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separated from the tissue signal by various techniques. The resonance frequency of a 
microbubble is partly dependent on its diameter (68) and by chance microbubbles with 
a diameter of 3-5 μm resonates with frequencies commonly used in imaging (3-
5MHz)(Figure 3). 
 
Figure 3: Microbubble diameter of Sonovue plotted against resonance frequency 
The mechanical index (MI) indicates the amount of negative acoustic pressure in tissue 
in an US field. It is indicated in all commercial US scanners as a safety measure and it 
is an indication of the probability of inducing tissue effects through streaming or 
cavitation. Commonly the MI is between 0.5 and 1 in regular B-mode imaging. 
However, this amount of acoustic energy will cause microbubbles to burst. To observe 
microbubbles over time low MI imaging is required. Typically, this means MI lower 
than 0.2. However, to minimize bubble destruction MI should be set as low as possible 
without compromising image quality.  
There are various ways to separate microbubbles from the tissue signal. All the 
resonating microbubbles generate harmonics or overtones. The second harmonic is 
double the transmit frequency and the easiest to detect, but also 3rd and 4th harmonics 
are produced as well as subharmonics (half the frequency). However, harmonics are 
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also reflected from the tissue and harmonic imaging has poor depth penetration due to 
attenuation and increasing sensitivity leads to reduced resolution.  
Pulse inversion is another technique where two pulses of fundamental frequency with 
inverted phases are sent along the same scan line and cancel each other out when they 
are received. The microbubbles on the other hand generate non-linear signals which 
are out of phase and can thus be separated from the tissue signal (69). In older pulse 
inversion techniques harmonics were also often generated contaminating the images 
with tissue signal. 
Non-linear fundamental signals can be detected with amplitude modulation. This 
technique seems to allow better cancellation of the tissue signal and the image 
resolution can be improved as the frequency of the non-linear received signal is close 
to the transmitted signal and a broader spectrum of signals can thus be received (70). 
In vitro studies have shown that there is a linear relationship between microbubble 
concentration and ultrasound intensity within the clinical range if large vessels are 
avoided (71). Also, exported video data can be re-linearized to provide estimates 
similar to radiofrequency data if the gain is not set too low or high and if the dynamic 
range of the video is over 45 decibel. If these criteria are met this permits a 
reproducible estimation of microbubble concentration over time and thus permits 
perfusion estimation (72). 
1.3.2 Perfusion estimation with CEUS 
According to the central volume theorem there is a fundamental relationship between 
blood volume (Bv) and mean transit time (MTT): 
஻௩
ெ்் ൌ ܤ݈݋݋݀݂݈݋ݓ  (5) 
Hence, if Bv and MTT of the blood through a location are known, blood flow can be 
calculated. In fact, knowing both Bv and MTT in a region could be more useful than 
knowing the blood flow alone. As both parameters contribute to the blood flow 
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estimate it could lead to better differentiation between conditions mostly affecting one 
parameter over the other.   
Currently, the two main techniques for measuring perfusion with CEUS are burst 
replenishment and bolus tracking. 
In the burst replenishment technique, the microbubbles are given as a continuous 
infusion. When steady state has been reached, all the bubbles in the imaging plane and 
in a small region surrounding it are burst by a high MI pulse (commonly MI=1).  
 
Figure 4:  Video-intensity plotted against time (seconds) for the burst-replenishment 
technique. When a steady contrast enhancement is obtained through constant 
infusion, the microbubbles in the imaging plane are burst with high MI ultrasound 
giving rise to a flash. This leads to the destruction of all the bubbles in the imaging 
plane, the intensity drops to base level and then reperfusion occurs to steady state 
again is obtained. (Video-intensity is used for illustration purposes since the 
linearized intensity has such a large range.) 
Then the reperfusion in the same area is observed (Figure 4). This reperfusion can be 
modelled as a simple increasing exponential curve (73) or the model can be made 
more complex to fit the anatomy of the micro-vasculature better (74). In the simple 
approach the signal-time intensity, S(t),  can be fitted to a mono-exponential function 
ܵሺݐሻ ൌ ߙሺͳ െ ݁ఉ௧ሻ  (6) 
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Where t is time in seconds, Į is the relative blood volume within the ROI and ȕ the 
mean flow velocity and Įȕ=mean relative flow (73). The parameters derived from 
such a model is however only proportional to the real perfusion parameters. 
Continuous infusion is also a complicated method for clinical use since it requires the 
use of an infusion pump specifically designed for the infusion of microbubbles. 
With the bolus tracking technique, the microbubbles are given as an intravenous bolus 
injection. The injection is commonly performed through a decubital vein and followed 
by a flush of saline. The examination is recorded from the time of injection and should 
include the arterial phase and parts of the venous phase. This means that the recording 
times will differ somewhat according to the organ which is examined. The time-
intensity data from a bolus injection can be used to calculate several semi-quantitative 
parameters (Figure 5) (75). 
The problem with this approach is that the intensity related variables are still only 
relative to the ultrasound equipment and the single contrast vial being used. Also the 
time variables such as time of arrival, time to peak and mean transit time are not 
comparable between patients since they do not take the injections speed, patient size 
and vascular tree into account. These factors are described by the arterial input 
function (AIF). 
There are different approaches for solving this problem. The AIF could be measured or 
estimated. To measure the AIF, the intensity in a single artery must be analysed over 
time.  In US images this can be extremely difficult and normal contrast doses can 
cause attenuation in the arteries leading to an underestimation of the AIF. A better 
approach might be to estimate the AIF in a pharmacokinetic model (76). 
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Figure 5: Video-intensity values plotted against time (seconds). From this curve 
several parameters can be derived such as time of arrival (TOA), rise time (RT), 
peak intensity (PI), slope and area under the curve (AUC). (Video-intensity is used 
for illustration purposes since the linearized intensity has such a large range.) 
Since microbubbles are purely intravascular agents and assuming a linear relationship 
between US intensity and microbubble concentration (71), they are perfect tracers for 
the analysis of perfusion using a single compartment model on an intravenous bolus 
injection. 
Assuming an infinitely short injection time and application directly to the analysed 
tissue, a pharmacokinetic model can be formulated as follows:  
ܥݐሺݐሻ ൌ ܤ݈݋݋݀݂݈݋ݓ ൈ ܥܽ ൈ ܴሺݐሻ (6) 
Where Ct(t) is the contrast concentration in tissue at given time t, Ca is the arterial 
concentration at time 0 and R(t) is the tissue residue function which is the fraction of 
contrast remaining in the tissue vasculature at time (t) after the infinitely short bolus, a 
function between 1 and 0. Blood flow has the unit ml/min/100ml tissue. 
Since the injection cannot be infinitely short in real life the equation must be 
reformulated as 
ܥݐሺݐሻ ൌ ܤ݈݋݋݀݂݈݋ݓ ൈ ܣܫܨሺݐሻ כ ܴሺݐሻ (7) 
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where the concentration of contrast in the arteries also is a function of time, the arterial 
input function or AIF(t). The equation states that the tissue concentration equals the 
convolution of the tissue residue function and the arterial input function. To derive 
blood flow from this equation the R(t) must be calculated using deconvolution which 
removes the dependency of the AIF. This approach is commonly used in MRI 
perfusion imaging of the brain where the MRI contrast does not leak over the blood-
brain barrier and thus behaves in much the same way as ultrasound contrast (76). 
 
Figure 6: Video-intensity data for the bolus and burst method plotted against time 
(seconds). The curve includes a bolus phase followed by a burst and a replenishment 
phase. (Video-intensity is used for illustration purposes since the linearized intensity 
has such a large range.) 
 A similar approach has been applied using CEUS (77;78), but only recently Jirik et al. 
presented a possible solution (79;80). This requires another way of acquiring the 
CEUS data which consists of injecting a contrast bolus followed by bursting the 
microbubbles when the arterial phase has passed and the contrast enhancement has 
reached a pseudo steady-state. This method is called bolus and burst since both the 
bolus passage and the burst replenishment is recorded in the same cine loop (Figure 6). 
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This enables the calculation of the mean transit time. The integral of the estimated AIF 
is scaled to the integral of an AIF measured in a local artery or from a separate 
recording. Finally, the blood flow is calculated according to equation (5). 
In summary, the burst-replenishment technique is practical in the sense that only the 
local perfusion in the GI wall is analysed and the AIF is not a concern. On the other 
hand it requires expensive equipment and a cumbersome set up and does not offer 
possibilities for absolute perfusion measurements. Bolus tracking can be used for the 
calculation of absolute perfusion, but issues concerning the correction for the AIF need 
to be resolved. The bolus and burst technique offers both the simplicity of a bolus 
injection with the possibility of estimating the arterial input function and thus enables 
the calculation of absolute perfusion parameters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 33
 AIMS OF THE STUDY 2.
The main aim of the thesis was to identify ultrasound findings that could be used to 
separate inflammatory from fibrotic stenosis in patients with Crohn’s disease. Three 
papers are included in this thesis. The specific aims of these papers were as follows 
 
I: To examine the echo properties of typical histological features for Crohn’s disease  
 
II: To establish reference values for the GI wall thickness and individual wall layers as 
measured by ultrasound and examine how they were affected by fasting state, US 
probe frequency and demographic factors. 
 
III: To examine if it was feasible to perform absolute perfusion measurements in CD 
patients fitting the time intensity data to a pharmacokinetic model and if there were 
differences in perfusion parameters, typical ultrasound findings and thickness of the GI 
wall and wall layers between patients with mainly fibro-stenotic disease and patients 
with mainly inflammatory disease using high frequency ultrasound and CEUS. 
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 MATERIALS AND METHODS 3.
3.1 Study population 
All patients in papers I and III were recruited at Haukeland University Hospital. The 
patients were either admitted to the bed wards, examined at the ultrasound and 
endoscopy unit or at the outpatient clinic at the time of recruitment. The patients were 
referred by the treating gastroenterologist or the gastroenterological surgeon 
contributing to the study. In paper I we included patients scheduled for bowel resection. 
In paper III we compared one group receiving medical treatment with another group 
receiving surgical treatment. 
The main investigator informed the patients and obtained written consent.  
All the patients undergoing surgery were examined with US within one week prior to 
surgery, but most of them the day before surgery. All the patients receiving medical 
treatment were examined within one week before start of treatment, the majority of 
them the same day as starting treatment and never later than three days after starting 
treatment. All patients were given the same surgical or medical treatment regardless of 
entering in the studies or not. 
In paper II healthy volunteers were recruited among the staff at Haukeland University 
Hospital through local adverts and a general e-mail invitation to all employees. 
Retirees were recruited by adverts through local organizations. In paper III 30 healthy 
volunteers were recruited through local adverts at Haukeland University Hospital and 
the University Campus. 
Paper I (n=14) and III (n=39) were explorative, pilot studies and for this purpose the 
number of patients included were considered sufficient. In paper II (n=122) a power 
analysis was done with regards to detecting possible demographic differences. 
Details on inclusion and exclusion criteria are further described in the corresponding 
papers. 
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3.2 Clinical scores 
Crohn’s disease activity index (CDAI) was developed and validated by Best et al. (81) 
It consists of a questionnaire registering disease specific symptoms the last 7 days 
before recording the data, findings and extra-intestinal features and a measurement of 
the erythrocyte volume fraction (EVF). The simple index or Harvey-Bradshaw index is 
a simplified version of CDAI only registering symptoms from the last two days (82). It 
has the advantage of being faster to record and not require actual weight measurements 
and blood sampling. 
3.3 Biochemical analysis 
Blood samples for patients in paper III were taken the same day as the US examination 
while stool samples were collected within a week or before surgery. In blood 
Haemoglobin (g/dl), erythrocyte volume fraction, leucocyte count (*109/L), platelet 
count (*109/L), C-reactive protein (mg/L) and albumin (mg/L) was analysed in the 
hospital laboratory facility as a part of the regular work up. The patients collected and 
delivered the stool samples themselves at first opportunity after the exam. Calprotectin 
(mg/kg) was analysed using an ELISA-kit. 
3.4 Macroscopic and histological examination 
In paper I the resected GI specimens were collected and inspected immediately after 
devitalization. The US setup is described in more detail in section 3.5.2. The 
sectioning was done by an experienced pathologist with the main investigator present.  
The sections corresponding to the US imaging planes were removed in one piece 
meaning that large whole mount slices had to be made since the width of the imaging 
plane was 40 mm.  Then 2 mm thick sections were embedded in paraffin, cut into 5 
μm thick slices and coloured according to standard procedures. Haematoxylin-eosin 
was used for standard histological evaluation and Masson-trichrome for the evaluation 
of fibrosis. 
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The histological findings were defined as follows: The muscularis mucosa was 
thickened if 0.3mm and Crohn’s rosary was considered present if there were 
lymphocyte aggregates along the serosal border 0.3mm. The cut-off was set to 0.3 
mm as this was just higher than axial resolution of the US probe. Fibrosis in the 
submucosa and muscularis propria were graded using a Likert scale from 0 to 2 where 
0= normal, 1=slight to moderate fibrosis and 2=severe fibrosis. Further details on the 
categorization are described in paper I. The histological examination was performed 
by the main investigator and an experienced pathologist. 
3.5 Ultrasound methods 
3.5.1 Ultrasound scanners and transducers 
Several different US scanners and probes were used throughout the study period. In 
paper I the US images were obtained with a 10 MHz linear array US probe and a 
SystemFive US scanner (GE Vingmed Ultrasound, Horten, Norway). In paper II all of 
the healthy subjects were examined with a Logiq 9 US scanner (GE Healthcare, 
Milwaukee, USA) while only some of the patients in study III were examined with this 
scanner. The Logiq 9 scanner was used with a curvilinear US probe (4C) and two 
linear US probes (9L and 12L). The rest of the patients in study III were examined 
with a Logiq E9 US scanner with a C1-5 curvilinear US probe and two linear probes 
(9L and ML6-15). Further details on the US equipment are described in the 
corresponding papers. 
3.5.2 In vitro ultrasound 
In paper I the US findings were compared directly to the findings in the resection 
specimens as this is considered as the gold standard for diagnosing and describing 
Crohn’s disease. The specimens were prepared by cutting them open in the 
longitudinal direction, cleaned with water and pinned in a specimen container filled 
with saline before being examined with US. The mucosal side of the intestine was 
facing up towards the US probe fixed in a purpose made holder attached to a micro-
positioner. To avoid reverberations and delineate the outer border of the specimen the 
 38
container was filled with an echo poor agar. The probe holder was equipped with 
needle channels on each side of the scanning plane, enabling precise marking of the 
scanning plane in the specimen with colour-coded needles. The in vitro set up was 
based on a study by Kimmey et al.(83) and details concerning the equipment and 
consumables are described in more detail in paper I.  
The muscular mucosa was considered thickened if there were two extra echo layers 
between the layers corresponding to the mucosa and submucosa. Lymphocyte 
aggregates along the outer border of muscularis propria were considered present if 
there were echo poor extensions from the muscularis propria layer into the serosa and 
subserosa. The echogenicity of the submucosal layer was categorised on a Likert scale 
ranging from 0 to 2. For the submucosa 0=echo rich (normal), 1= echo rich with 
sporadic echo poor elements, 2= echo rich with diffuse echo poor elements. For the 
muscularis propria layer 0= echo poor (normal), 1= echo poor with sporadic echo rich 
elements, 2= echo poor with diffuse echo rich elements. 
3.5.3 B-mode 
In paper II the healthy subjects were initially scanned with the curvilinear probe 4C for 
the measurement of wall thickness in the gastric antrum and duodenum since these 
areas sometimes are so deeply located that they cannot be imaged with high frequency 
US probes. For the same reason the rectum was only examined with the 4C.  All 
locations except for the rectum were scanned with the 9L set to 8 MHz and the 12L set 
to 12 MHz.  Starting from proximally in the GI tract the measurements were done in 
the gastric antrum, duodenal bulb, jejunum located in the upper left quadrant, jejunum 
located in the lower left quadrant, terminal ileum, ascending, transverse, descending 
and sigmoid colon. The wall thickness was measured in the anterior wall of the bowel 
from the start of the echo poor layer corresponding to the muscularis propria to the end 
of the echo poor layer corresponding to the mucosa (See figure 1 in paper II). The 
thickness of the echo layers corresponding to the mucosa, submucosa and muscularis 
propria for the same location were also measured in the ileum and sigmoid colon. Two 
measurements were made in each location and averaged. Details on how the 
measurements were optimized to avoid overestimation of wall thickness are further 
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described in paper II. In eight randomly selected healthy subjects measurements of the 
ileum and sigmoid colon were repeated by a second observer blinded to the 
measurements from the main investigator for estimating interobserver variability. 
In paper III the patients were first scanned with the curvilinear abdominal probe to 
look for areas with affected intestine and to get an overview. Then the scan was 
repeated with the linear probe. The US probe with the highest frequency range was 
used if possible. The scanning was performed systematically starting in the right iliac 
fossa. First the colon was followed from the ileocecal valve to the rectum, and then the 
small intestine was scanned from the right iliac fossa towards the upper left quadrant. 
Every time a pathological area was found its location was noted and measurements 
performed. The affected or stenotic area with the thickest GI wall was chosen for 
examination with CEUS. 
The location and length of each affected segment was noted as well the presence or 
absence of complications such as abscesses, stenosis or fistulas in association with the 
affected segment. The measurements of GI wall thickness and layer thickness were 
performed as in paper II except that the average of three measurements for each 
location was used. 
3.5.4 Doppler techniques 
In paper III colour Doppler was performed with the 12L (Logiq 9) and the ML6-15 
(Logiq E9). Both probes were set with a velocity scale of ± 2 cm/s for detection of 
blood flow in arteries within the GI wall. Gain was increased to flash artefacts occurred 
and then reduced to the artefacts subsided. Colour Doppler was scored using a Likert 
scale from 0-2 where 0=0-2, 1=3-5 and 2=>5 colour Doppler signals per square 
centimetre (58). Pulse wave Doppler of an artery in the submucosa was performed in 
triplex mode when possible and the resistive index of three cycles were measured and 
averaged. 
3.5.5 Contrast enhanced ultrasound  
In paper III CEUS was performed in contrast mode on the US scanner, using the general 
setting and an MI of 0.10-0.12. The bolus injection of 4.4 ml ultrasound contrast 
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(Sonovue, Bracco, Milan, Italy) was chosen after pilot examinations indicating that this 
was the best dose for detecting intensity changes in the GI wall.  The contrast was 
injected over 2 seconds through a 20 gauge venflon in a decubital vein followed by a 
flush of 10 ml 0.9% NaCl over 4 seconds. Approximately 55 seconds after injection the 
bubbles in the imaging plane were burst using a high MI flash and the observation 
continued for further 30 seconds. A continuous video recording including a short 
prebolus phase, bolus and replenishment phases was stored as a single 90 second loop. 
The same procedure was performed in the healthy volunteers except attempts were 
made to include both a part of the terminal ileum and the ascending colon in the frame. 
If both could not be included either due to excessive peristalsis in the terminal ileum or 
if the cecum covered the ileum, the ascending colon was the preferred target for 
observation. 
3.6 Software for perfusion analysis 
In co-operation with Radovan Jirik and colleagues a software for the analysis of CEUS 
data for the extraction of perfusion information was developed 
(http://www.isibrno.cz/perfusion/). The software offers the possibility to upload video files 
in DICOM -format, down-sample the cine loops to a more convenient size by reducing 
frame rate, automatic and manual motion correction, conversion of log-converted video 
data to acoustical units approximately linear to the radio-frequency data, selection of 
several regions of interest, selection of arterial input function for scaling and two new 
pharmacokinetic models for the calculation of absolute perfusion. 
3.7 Post-processing of exported video-loops 
The video data from the contrast recordings were exported as DICOM files. These were 
imported into the DCE-US software. To reduce the computational load the videos were 
down-sampled from 4-11 frames/second to about 2 frames per second leaving a 
maximum of 180 frames per video. Several methods using automatic and manual 
motion correction were tested (84;85), but in the end the fastest and most robust method 
available was a manual correction which could correct for translational displacement, 
but not rotation or deformation. Off plane frames were excluded from the analysis. As 
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the intensity information in the video data consists of log-converted data this had to be 
re-linearized using a conversion module in the software. The conversion was done with 
respect to the dynamic range of the video. Then a region of interest was chosen in the 
anterior wall of the affected intestine and the time intensity data were analysed using the 
modified bolus and burst algorithm (79;80).  Finally, the results from this analysis were 
scaled. This was done by scaling the estimated AIF to the AIF measured in an artery in 
the same recording. While the end product of the perfusion analysis was the mean 
transit time, the scaling procedure gave the blood volume. From these two parameters 
blood flow was calculated. 
3.8 Ethics 
All studies were approved by the Regional Ethics Committee for western Norway and 
conducted according to the Helsinki Declaration. All patients and healthy volunteers 
gave their informed consent before participating in the studies.  
3.9 Statistics  
Paper I was descriptive and only the absolute number of the different variables were 
presented. In paper II SPSS version 15.0 and in paper III IBM SPSS statistics 19.0 was 
used. The details of the analysis performed are presented in the different papers. 
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 SUMMARY OF PAPERS 4.
Paper I and III included patients operated for CD. In the first the intestine was 
examined with US in vitro while in the third they were examined prior to surgery. A 
group of patients treated medically for an exacerbation of CD were also included in 
paper III. Healthy volunteers were included as a reference material in paper II and as a 
control group in paper III. 
 Paper I: 4.1
The purpose of this study was to compare histological findings in resected bowel from 
patients with CD with US images to investigate if findings typical for CD had 
corresponding US features. Specimens were examined with a 10 MHz linear US probe 
in an in vitro set up ensuring an accurate marking of the imaging planes. Several 
sections (3-9) from each specimen were made according to the markings and from 
each section several regions of interest (ROI) (1-3) were chosen for comparison. There 
were altogether fourteen patients, 58 sections and 123 ROIs. Thickened muscularis 
mucosa (0.3 mm) was found in 48 of 69 ROIs. Submucosa with slight to moderate 
fibrosis was found in 36 of 56 ROIs, while severe fibrosis was seen in 40 of 55 ROIs. 
Slight to moderate fibrosis of muscularis propria was seen in 49 of 66 ROIs and severe 
fibrosis was seen in 17 of 22 ROIs. Crohn’s rosary was seen in 31 out of 50 ROIs. We 
concluded that typical changes in CD did have US characteristics that could be 
detected and that increasing fibrosis seemed to cause an increase of echogenicity in the 
muscularis propria and a decrease of echogenicity in the submucosa. 
 Paper II: 4.2
The aim of this study was to establish reference values for GI wall thickness and 
thickness of individual wall layers in the GI tract as well as determining if these 
parameters are dependent on demographic factors, transducer frequency and fasting 
state. We examined 122 healthy subjects aged 23 – 79 with both 8 and 12-MHz 
transducers. Twenty-three subjects were given a test meal and re-examined after 30 
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minutes. The mean wall thickness was less than 2 millimetres including two standard 
deviations in all sections of the GI tract except the antrum, duodenum and rectum. The 
overall wall thickness was dependent on weight, age and probe frequency used in the 
study. The wall thickness also increased in the ileum and sigmoideum after the test 
meal. The differences were not large enough to require a correction of the reference 
values. 
 Paper III: 4.3
The purpose of this study was to investigate the feasibility of absolute perfusion 
measurements with CEUS in Crohn’s patients and examine if there were differences in 
bowel wall perfusion between patients with mainly inflammation and patients with 
mainly fibrosis. For this reason we chose to compare patients scheduled for surgical 
treatment (n=20) with patients receiving medical treatment for a flare up (n=19).  The 
patients were examined with transabdominal US including CEUS close to the start of 
treatment as well as clinical and biochemical indices of disease activity and 
inflammation. 
We found that absolute perfusion estimation was feasible in 90% of the patients. 
Furthermore, there was a significantly lower blood volume in patients receiving 
surgery for CD compared to those with an acute flare up (p=0.001) and healthy 
subjects (p=0.005). Blood flow was also lower in the surgery group when compared to 
the medical group (p=0.006). As expected the GI wall was thicker in the surgery group 
(p<0.001), and this seemed to be reflected in a significantly thicker mucosa (p=0.005) 
and muscularis propria (p<0.001) while the submucosal thickness was not different 
between the two groups. 
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 RESULTS AND DISCUSSION 5.
5.1 Normal findings with ultrasound in the GI tract 
In paper II, we found that the average wall thickness for both the small and large 
bowel was below 1.2 mm. This is comparable to the study by Haber  et al. (32)  using 
a linear 7 MHz probe which is the only other study looking at comparatively large 
number of subjects. Older studies (34;86) report considerably higher values. 
The differences in results might be attributed to the equipment, higher frequency 
probes with potentially better resolution and better post-processing of images. This is 
supported by the result showing that the GI wall is measured as thicker using 8 versus 
12 MHz frequency. This is also a paradoxical finding as a lower resolution probe 
actually should make the anterior GI wall appear thinner since it will cause thicker 
interface echoes and thus less of the actual muscularis propria will be included in the 
measurement. We believe this is due to a selection bias. US probes with a low 
resolution will produce images where parts of the GI tract simply cannot be discerned. 
The operator will then perform the measurements in areas which on average have a 
greater wall thickness. In our study, the difference between the two probes was 
statistically significant, but so small that it probably does not have any diagnostic 
implications. One could speculate that this has higher impact when using probes with 
lower frequencies. The limit of the lateral resolution is half the spatial pulse length of 
the US beam given by equation (2). Since both the wavelength is longer and the 
number of pulses per cycle commonly higher in a 3-5 MHz probe compared to a high 
frequency probe (>7.5MHz) the combined effect will cause large differences in axial 
resolution. 
While we found that the mean and 2SD was less than 2 mm for all locations in the GI 
tract but the antrum, duodenum and rectum, many recent studies used 3 or 4 mm as a 
cut off between healthy and pathological bowel (36-39;87;88). This will reduce false 
positive findings, but also compromises sensitivity. In our institution experienced 
colleagues performing bowel sonography of patients with IBD often notice a “marked 
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bowel wall” when they find a wall between 2 and 3 mm. This finding sometimes 
corresponds with pathological findings on ileocolonoscopy. Lowering the cut off to 2 
mm would mean that these patients would be considered as having bowel wall 
affection.  
Finally, we found that the overall wall thickness in the GI tract was dependent on both 
weight and age and that this effect was more pronounced in parts of the GI tract.  We 
also found that the ileum and sigmoid colon becomes thicker after a meal. While the 
postprandial thickening can be explained by the gastro-ileal and gastro-colic reflexes, 
we have no clear explanation for the weight and age dependency (89). The most 
important conclusion that can be drawn from these data is that even though weight, 
age, fasting state and probe frequency does influence the wall thickness measurements, 
the effect on the reference values seems to be of no clinical importance 
5.2 Pathological ultrasound findings in patients with CD 
In paper I the US characteristics of histological findings typical for CD such as fibrosis 
of the submucosa and muscularis propria, thickening of the muscularis mucosa and 
Crohn’s rosary (14;15;19) were identified and categorised. In paper III it was 
demonstrated that some of these findings seem to occur more frequently in patients 
operated for CD which corresponds to previous studies indicating that these 
histological findings appear to be typical in chronic inflammation and fibrosis 
(15;19;90;91). There were no significant differences in the echogenicity of muscularis 
propria between the two groups in paper III, but fibrosis of the muscularis propria is 
more rare (15) and was clearly less frequent in the areas examined in paper I (Severe 
submucosal fibrosis 54/123. Severe fibrosis of muscularis propria: 22/123).  
In paper III, the thickest GI wall was found in the patients operated for CD. This 
corresponds with previous studies showing that a thickened GI wall increases the risk 
for surgery (37;92;93).  Since the indication for surgery in most instances is stenotic 
obstruction, this is to be expected. A more interesting finding was that the mucosa and 
muscularis propria was significantly thicker in patients operated for CD than compared 
with those receiving medical treatment. In contrast Fritscher-Ravens found that 
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thickening of the submucosa is a typical feature in acute CD (94). Pathological 
examination of resected specimens typically show that the submucosa is thickened in 
the acute stages of the disease due to oedema (15). The thickening persists due to 
collagen depositions and the collagen gradually causes a loss of compliance between 
the submucosa and the muscularis propria and in turn a thickening of all wall layers 
(90). Accordingly, the US finding of a relatively thick submucosal layer in a thickened 
GI wall could be a sign of acute disease while a thickened GI wall with general 
thickening of all wall layers could be a sign of chronic fibrotic disease. 
5.3 CEUS perfusion measurements of bowel 
In paper III the feasibility of absolute perfusion measurement of the bowel wall was 
demonstrated. Although, technically challenging the examination and post-
examination analysis could be performed in most of the patients and the results had a 
fair degree of intraobserver reproducibility. The most technically difficult part was the 
examination of the healthy bowel and the scaling procedure. Erroneous scaling will 
cause faulty blood volumes which again will cause errors in the blood flow estimate.  
The small ROIS in the thin healthy intestinal wall causes noisy time-intensity data 
which in turn can cause a large variation in the mean transit time estimate. This was 
probably reflected in the large range of perfusion parameters that we found, 
particularly in the healthy subjects 
Several authors have attempted to measure the local perfusion in the GI wall with 
various methods either with imaging methods such as CT, MRI and US (95-100) or 
more invasive methodology such as per-operative laser Doppler or isotope wash out 
techniques (101-103). However, very few studies report absolute values of perfusion 
and none recently. Those that do have correlated their relative values to the actual 
blood flow measurements in segments of the bowel during open abdominal surgery 
and subsequently derived absolute values. 
Hulten et al. using a wash-out technique with a radioactive isotope of Krypton found 
that blood flow in the small bowel was 38 (17-75) ml/min/100g and the colon 18 (8-
35) ml/min/100g tissue in healthy volunteers (104;105). Ahn et al. found similar 
results with per-operative laser Doppler (Jejunum  38 ± 15 ml/min/100g and ileum 30 
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± 13ml ml/min/100g tissue), but when measuring through an endoscope in patients not 
under general anaesthesia, he found significantly higher flow results in the colon: 37 ± 
10.4 ml/min/100 ml tissue (101;102). Studies of patients with CD indicate that there is 
increased flow in the colon in the acute phase and reduced in more chronic disease. 
The same studies show no increase of flow in the small intestine in the acute phase, 
but a decrease in chronic disease (103;106). However, laser-Doppler measurements 
may underestimate high flow and is also affected by wall thickness (102). This could 
partly explain the reduced perfusion observed in CD by Tateishi (106). 
Although our method needs improvement to increase reproducibility, the average 
values of blood flow are fairly consistent with the values found in previous studies 
(101-106). As previously mentioned, perfusion modelling also offers more variables 
than the actual blood flow which could be important for diagnostic differentiation. For 
instance, neo-vascularisation is a feature of inflammation in CD (107-109) and 
reduced capillary density is a feature of fibrosis (103;110). These are factors which 
could be reflected in increased and reduced blood volume, respectively. Increased 
vascular resistance is another finding in acute CD (111-113) which in turn could affect 
mean transit time. Interestingly, we found reduced blood volume in the surgical group 
where more fibrotic disease should be expected as compared to the medical group. 
However, there were no significant differences between any of the groups with regards 
to mean transit time. This could be caused by a large variability due to heterogeneous 
groups or inaccuracy of the current method. A study comparing the micro-vessel 
density in the resection specimens with the blood volume and the degree of 
histological inflammation with the mean transit time may further enhance our 
understanding. 
5.4 Fibrosis and inflammation  
As stated previously there are some US findings which could be useful in the 
differentiation of fibrotic and inflammatory disease in CD. Factors indicating 
inflammation are a thickened GI wall with loss of stratification, increased Doppler 
signals from the GI wall and a thickened submucosa. Preserved stratification in a 
thickened GI segment suggests fibrosis (52). CEUS can also be used to detect 
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increased vascularity or blood flow within the GI wall thus indicating an area of 
inflammation (38;62;63) although there is conflicting evidence (98). 
The papers presented in this thesis show that US findings indicating a mainly fibrotic 
CD lesion are the thickening of the muscularis mucosa, hypo-echoic elements in the 
submucosal layer, a combination of GI wall thickening and overall thickening of all 
US layers, as well as reduced blood volume and flow. US findings supporting the 
presence of a mainly inflammatory CD lesion are overall thickening of the bowel wall 
and thickening of the submucosa together with a normal blood volume and flow. We 
did not find significant differences in stratification between the patients receiving 
medical or surgical treatment. In paper I some or all of the US wall layers could be 
detected in all sections, while in paper III, total loss of stratification was present in 
only 4 patients. This suggests that loss of stratification might not be a promising 
marker of acute inflammation. 
5.5 Other limitations: 
In this thesis various US techniques have been used. With the introduction of a new 
technique the examiner’s learning curve might affect reproducibility. The primary 
investigator performed the examination and inclusion in paper I under close 
supervision with experienced investigators. Before inclusion in paper II and III the 
primary investigator had altogether two years’ experience of clinical US and 6 months 
of intensified training focused on bowel US.  
When introducing a new method it should be compared to a reference standard. For 
CD this is the resection specimen examined by the pathologist. For most patients this 
is not available and those who are operated have more serious and long standing 
disease than others. Typical histological findings for the whole GI wall in people 
receiving only medical therapy such as in paper III are therefore not known. 
In paper I, the findings were evaluated by several investigators, but not blinded and 
decision was reached by consensus. In paper II a randomly selected subgroup was 
examined by another operator to investigate interobserver variability. Only some of the 
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measurements were repeated, however, and theoretically the variability could be larger 
in other locations. The results from paper III should be viewed with some caution as 
the perfusion method has not been validated. 
5.6 Conclusions and future perspectives 
In summary, the normal GI wall thickness is generally below 2 mm regardless of 
fasting state or other demographic factors. In CD the GI wall is thickened and while 
the submucosa is thickened in acute disease the development of fibrosis seems to 
cause a thickening of all wall layers that can be discerned with US. There are typical 
histological findings in CD representing chronic inflammation and fibrosis which can 
be recognised with US. There were no differences in perfusion between healthy 
volunteers and patients with an acute flare up, but patients with chronic disease 
needing surgery had lower blood volume and flow. 
Future work should involve a comparison of the perfusion parameters with histological 
findings, particularly micro-vessel density. Also the usefulness of these parameters in 
predicting prognosis and treatment effect should be tested in prospective studies. The 
perfusion model must be validated using a gold standard and the analysis simplified 
before implementation in clinical work. The challenges with absolute perfusion 
analysis of the GI wall can be partially overcome by improving microbubble and US 
technology. 3D contrast ultrasound will improve motion correction as there will be no 
out-of-plane motion and also reduce the problem of sampling error. Furthermore, more 
stable microbubbles will allow multiple injections from the same vial allowing the 
scaling to be done using a second low-dose injection when looking at a large artery.   
CD is a debilitating disease concerning a relatively large population of young people. 
The development and improvement of simple, objective and non-harmful diagnostic 
tools is one way of making it easier for these patients to live with the disease. 
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